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cancerDear Editor,
Moraxella osloensis is an aerobic, Gram-negative cocco-
bacillus (formerly classified as Moraxella nonliquefaciens).
The clinical significance and appropriate therapy for pa-
tients with M. osloensis bacteremia are not well studied.
Here, we report a case of a male patient with lung cancer
who presented with M. osloensis bacteremia complicating
with pneumonia. The species was initially identified as
Comamonas testosteroni using a commercially automated
system, and was reidentified as M. osloensis using Bruker
Biotyper matrix-assisted laser desorption ionizationeat the
time of flight mass spectrometry (MALDI-TOF MS; Bruker
Daltonics, GmbH, Bremen, Germany) and partial 16S ribo-
somal DNA gene sequencing analysis.
Thepatient receivedadiagnosis of lung cancer of the right
upper lobe 4 years ago. He suffered from fever and cough for
2 days before admission, and a chest radiograph showed in-
filtrations of the right lower lobe of the lung (Figure 1). He
used a bilateral positive airway pressure ventilator for
pneumonia with acute respiratory failure. The laboratory
data revealed the results of white blood cells 9070 cells/mL
with 83% neutrophils, hemoglobin 11.9 mg/dL, platelets
242,000 cells/mL, serum glucose 254 mg/dL, creatinine
2.34 mg/dL, blood urea nitrogen 18 mg/dL, and C-reactive
protein 19.8 mg/dL. The patient received empirical therapy
with intravenous cefoperazone/sulbactam 2 g/2 g every 12
hours initially. Four days later, the results of blood culture
were identified as C. testosteroni using the Phoenix 100 ID/
AST system (Becton Dickinson, Sparks, MD, USA). The isolate
was presumptively identified as M. osloensis (score value
1.848) using Bruker Biotyper MALDI-TOF (Bruker Daltonics).
The result of Gram stain of the colonies showed coccobacilli.
Sequencing analysis of partial 16S ribosomal DNA gene of the
isolate was performed with two primers: 8FPL (50-
AGAGTTTGATCCTGGCTCAG-30) and 1492 (50-GGTTACCTTGPlease cite this article in press as: Lee W-S, et al., Moraxella osloensis
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withpublished sequences in theGenBankdatabase, using the
BLASTN algorithm (http://www.ncbi.nlm.nih.gov/blast).
The isolate was identified asM. osloensis (accession number
KC456542.1) with maximal identity of 100% (858/858 bp).
The antimicrobial susceptibility test showed that the
isolate was resistant to cefazolin, cephalexin, penicillin,
ampicillin, and amoxicillin/clavulanate, but susceptible to
levofloxacin, ciprofloxacin, ceftazidime, cefepime, cefo-
perazone/sulbactam, amikacin, gentamicin, and carbape-
nems (doripenem, imipenem, and meropenem) using the
Phoenix 100 ID/AST system (Becton Dickinson). The patient
was discharged on hospital Day 21 to complete a 14-day
course of cefoperazone/sulbactam therapy.
Among the Moraxella species, M. catarrhalis is the most
common isolate of the respiratory tract. M. osloensis has
been isolated from the respiratory tract, blood, cerebro-
spinal fluid, and urine.1,3 Clinical reports of infections
caused by M. osloensis are rare.1 M. osloensis has been
implicated in community-acquired pharyngitis, septic
arthritis, meningitis, ophthalmitis, and otitis media.1e5
Hospital-acquired central venous catheter infections in an
elderly woman receiving chronic parenteral nutrition have
also been reported.1,6 Our patient with M. osloensis
bacteremia complicated with pneumonia is different from
previous case reports. M. osloensis is often misidentified as
C. testosterone,2 and molecular methods may be required
to confirm the species identification. The appropriate
treatment of bacteremia due to M. osloensis has not been
well studied. In past decades, M. osloensis has been found
to be sensitive to penicillin, first-generation cephalospo-
rins, and aminoglycosides.5 Although, our patient had been
resistant to penicillin, amoxicillin/clavulanate, and cefa-
zolin. However, the prognosis for patients with M. osloensis
infections is generally good.1e5 Further studies are stillbacteremia complicating with severe pneumonia in a patient with
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Figure 1. Chest radiograph revealing the infiltration patch of
the right lower lobe of the lung.
2 Correspondence
+ MODELrequired to evaluate the clinical manifestations, diagnosis,
and antibiotic resistance of infections due to M. osloensis.
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